Merck Sharp & Dohme LLC (MSD) is a research-intensive biopharmaceutical company with a history spanning more than 130 years. Its core business involves the development of medicines and vaccines for both people and animals. The company operates across the United States and Canada, with technical domains in biopharmaceutical research, vaccine development, and veterinary medicine.
The company's portfolio includes historically significant products such as Streptomycin, a breakthrough antibiotic that helped reduce tuberculosis deaths by nearly 50% by 1950. Its MSD Animal Health division provides innovative veterinary solutions that support public health, food safety, and global protein supplies. The company states it currently has one of the most diverse pipelines in its history.
MSD's stated operating philosophy holds that medicine is for the people, not for the profits. The company aspires to be a premier research-intensive biopharmaceutical firm and follows the science where it can make the greatest difference. Its industry verticals include biopharmaceuticals, veterinary health, public health, and food safety.
